健康去哪儿
健趣网登录 关闭
还没有账号?立即注册

Effects of Measurement of Handgrip Strength on Physical Activity Level for Patients With Diabetes Type 2

Sponsor:
Collaborators:
Information provided by (Responsible Party):
August 24, 2018
October 3, 2018
October 3, 2018
October 1, 2018
October 1, 2020   (Final data collection date for primary outcome measure)
Change in physical activity level[ Time Frame: Change from baseline at 1 year. ]
Two questions evaluating frequency and intensity of physical activity according to recommendations by the American College of Sports Medicine and the American Heart Association.

Same as current
  • Change in handgrip strength[ Time Frame: Change from baseline at 1 year. ]
    Handgrip strength in kg measured with Jamar handdynamometer
  • Change in HbA1c[ Time Frame: Change from baseline at 1 year. ]
    Blood test. HbA1c level measured in mmol/mol
  • Change in waist circumference[ Time Frame: Change from baseline at 1 year. ]
    Waist circumference in cm measured with tape measure while standing
  • Physical Activity on Prescription[ Time Frame: Change from baseline at 1 year. ]
    Total number of prescriptions for physical activity issued by participating diabetes-nurses. Differences measured between groups.
 

Effects of Measurement of Handgrip Strength on Physical Activity Level for Patients With Diabetes Type 2

Does Measurement of Handgrip Strength Affect Physical Activity Level for Patients With Diabetes Type 2? A Randomized Controlled Trial

Background: It is recommended that patients with diabetes type 2 keep themselves physically active and it is known that good muscular strength has a positive effect on these patients. Aim: To determine whether physical activity level increases and whether other risk factors for cardiovascular disease are positively affected by including measurement of handgrip strength as part of the regular care program for patients with diabetes type 2 in primary care. Method: Patients with diabetes type 2 who go to regular check-ups by participating diabetes-nurses in primary care are randomized to either intervention or control group. In the intervention group, handgrip strength is measured in addition to standard care. the control group receives standard care at inclusion. Handgrip strength is measured in both groups at 1 year follow-up. Physical activity level is measured in both groups at inclusion and 1 year follow-up with a questionnaire. Measurement of other risk factors for cardiovascular morbidity are measured at both inclusion and follow-up in both groups as dictated by standard care routines. Expected results: Measurement of handgrip strength can give health care personnel greater possibilities to identify those patients with diabetes type 2 who need to increase their activity level and to give them more concrete support. It is possible that the attention given to handgrip strength and physical activity may motivate patients to increase their activity level, become stronger and eventually reduce other risk factors for cardiovascular morbidity.

Interventional
N/A
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Masking: Interventional
Masking Description:
Primary Purpose: Supportive Care
  • Device: Handgrip strength measurement
    Measurement of handgrip strength with Jamar hand-held dynamometer as a complement to standard care of patients with diabetes type 2 by diabetes-nurses.
  • Other: Standard care
    Standard care of patients with diabetes type 2 by diabetes-nurses.
  • Experimental: Intervention group
    Standard care at yearly check-up by diabetes-nurse in primary care. Handgrip strength measurement bilaterally. Measurement of physical activity level.
  • Active Comparator: Control group
    Standard care at yearly check-up by diabetes-nurse in primary care. Measurement of physical activity level.
 
Not yet recruiting
800
Same as current
October 1, 2020
October 1, 2020   (Final data collection date for primary outcome measure)
Inclusion Criteria: - Patients with diabetes type 2 who go to regular check-ups with participating diabetes-nurses at primary health care centres in Region Västra Götaland, Sweden. Exclusion Criteria: - No gender, age or language restrictions.
Sexes Eligible for Study: All
N/A and older   (Adult, Older Adult)
No
 
 
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: No
Göteborg University
Study Director: Margareta Hellgren, PhD Närhälsan
Study Director: Maria EH Larsson, PhD Närhälsan
October 2018

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP
请使用微信扫码报名